4 Momentum Stocks To Watch

These four stocks are moving on news and gaining technical momentum:

Axsome Therapeutics, Inc. AXSM jumped $8.60 to $89.57 on 2.6 million shares Wednesday, more than double its average volume. On Monday the biotech company said its experimental treatment for depression met the primary endpoint in a Phase 3 clinical trial.

The move popped the stock through the top of an already steep channel rising from the $20 level just two months ago. Watch for $106 next.


Bed Bath & Beyond Inc. BBBY gained 84 cents to $17.72 on 10.5 million shares Wednesday. The move followed news of a restructuring in which six senior leaders are leaving the specialty retailer. The stock has been stair-stepping up its rising channel since its mid-August low at $7.31, and the channel top now points to a target of $20-$20.50.


ImmunoGen, Inc. IMGN climbed 35 cents to $4.97 on 7.5 million shares Wednesday, more than triple its average volume. On Tuesday the biotech company announced the FDA cleared a trial that could support accelerated approval for its investigational ovarian cancer drug. That news propelled a move that popped the stock out of a falling wedge and through channel and lateral resistance. The next target is $6.


comScore, Inc. SCOR rose 29 cents to $5.19 on 1.2 million shares Wednesday. On Tuesday the company announced an agreement to provide Publishers Clearing House with digital audience measurement. The stock has risen sharply from below $2 two months ago, and the channel top points to a target of $7.25.


See Harry's video chart analysis on these and 15+ other top charts.


No holdings.

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

Image Sourced from Pixabay

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechGovernmentNewsRegulationsGuidanceCommoditiesRetail SalesMarketsTechGeneralstockstech stocksTheTechTrader
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...